Dr. Clark Y. Lin is a partner in Wilson Sonsini Goodrich & Rosati's New York office. He practices intellectual property law, with an emphasis on patent prosecution, general intellectual property counseling, and intellectual property litigation. Clark focuses on developing, managing, and leveraging global patent portfolios for life science companies. His patent expertise includes the fields of immunotherapies, specialty pharmaceuticals, antibody and protein therapeutics, gene therapies, cell therapies, CRISPR gene editing and RNA therapies. With experience in over 20 issuer-side public offerings, Clark also assists life science companies through the IPO process from an intellectual property perspective.
While in graduate school, Clark investigated signal transduction of intracellular pathways involved in cellular proliferation, differentiation, programmed death, and stress response. Prior to joining the firm, Clark interned as a law clerk for the Washington State Office of the Attorney General and for the University of Washington Office of Technology Transfer, where he worked on a variety of intellectual property matters, including trademark enforcement, software license agreement drafting, copyright infringement, and evaluations of university research for IP protection.
Dr. Clark Y. Lin is a partner in Wilson Sonsini Goodrich & Rosati's New York office. He practices intellectual property law, with an emphasis on patent prosecution, general intellectual property counseling, and intellectual property litigation. Clark focuses on developing, managing, and leveraging global patent portfolios for life science companies. His patent expertise includes the fields of immunotherapies, specialty pharmaceuticals, antibody and protein therapeutics, gene therapies, cell therapies, CRISPR gene editing and RNA therapies. With experience in over 20 issuer-side public offerings, Clark also assists life science companies through the IPO process from an intellectual property perspective.
While in graduate school, Clark investigated signal transduction of intracellular pathways involved in cellular proliferation, differentiation, programmed death, and stress response. Prior to joining the firm, Clark interned as a law clerk for the Washington State Office of the Attorney General and for the University of Washington Office of Technology Transfer, where he worked on a variety of intellectual property matters, including trademark enforcement, software license agreement drafting, copyright infringement, and evaluations of university research for IP protection.
- J.D., University of Washington School of Law, 2008
- Ph.D., Neurobiology, Pharmacology & Physiology, University of Chicago, 2005
- B.A., Molecular & Cell Biology and Music, University of California, Berkeley, 1997
- Named one of “Top 25 Attorneys of Massachusetts for 2022” for his practice in intellectual property law and his emphasis on patent prosecution and general IP counseling
- State Bar of California
- State Bar of Massachusetts
- State Bar of New York
- U.S. Patent and Trademark Office
- J.D., University of Washington School of Law, 2008
- Ph.D., Neurobiology, Pharmacology & Physiology, University of Chicago, 2005
- B.A., Molecular & Cell Biology and Music, University of California, Berkeley, 1997
- Named one of “Top 25 Attorneys of Massachusetts for 2022” for his practice in intellectual property law and his emphasis on patent prosecution and general IP counseling
- State Bar of California
- State Bar of Massachusetts
- State Bar of New York
- U.S. Patent and Trademark Office
Select Publications
-
Author, “PTAB Determines Broad Has Priority in Dispute over CRISPR Gene Editing Patents in Eukaryotic Systems.” Wilson Sonsini Alert, March 2, 2022
-
Co-author with H. Gao and L. Lieto, ”Massachusetts State Senator Files Second Attempt at Bill to Address Bad Faith Patent Infringement Assertions," Intellectual Property & tech Law Journal, 31(7), July 2019
-
Co-author with L. Westin, J. Guise, D. Carsten, V. Norviel, ”District Court Denies Amgen’s Bid to Block Sale of Blockbuster Biosimilar Drug," WSGR Alert, March 19, 2015
-
Co-author with V. Norviel, “The Effects of Government Grant Applications on the Patentability of Life Sciences Technologies,” The Life Sciences Report, Spring 2010, 9-10
- Co-author with B. Franco and M.R. Rosner, "CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders," 14(24) Human Molecular Genetics 3775-86, 2005
- Co-author with Z. Qian, R. Espinosa, M. LeBeau, and M.R. Rosner, "Cloning and Characterization of MST4, a novel Ste-20-like kinase," 276(25) Journal of Biological Chemistry 22439-45, 2001
Select Speaking Engagements
- Speaker, ”Third-Party Intellectual Property and Disputes,” Innovator’s Edge Series, Aug 2021
- Speaker, “IP 101, The Basics for Biotech & Life Science Startups,” Tufts Launchpad | Biolabs, Oct 2018
Select Publications
-
Author, “PTAB Determines Broad Has Priority in Dispute over CRISPR Gene Editing Patents in Eukaryotic Systems.” Wilson Sonsini Alert, March 2, 2022
-
Co-author with H. Gao and L. Lieto, ”Massachusetts State Senator Files Second Attempt at Bill to Address Bad Faith Patent Infringement Assertions," Intellectual Property & tech Law Journal, 31(7), July 2019
-
Co-author with L. Westin, J. Guise, D. Carsten, V. Norviel, ”District Court Denies Amgen’s Bid to Block Sale of Blockbuster Biosimilar Drug," WSGR Alert, March 19, 2015
-
Co-author with V. Norviel, “The Effects of Government Grant Applications on the Patentability of Life Sciences Technologies,” The Life Sciences Report, Spring 2010, 9-10
- Co-author with B. Franco and M.R. Rosner, "CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders," 14(24) Human Molecular Genetics 3775-86, 2005
- Co-author with Z. Qian, R. Espinosa, M. LeBeau, and M.R. Rosner, "Cloning and Characterization of MST4, a novel Ste-20-like kinase," 276(25) Journal of Biological Chemistry 22439-45, 2001
Select Speaking Engagements
- Speaker, ”Third-Party Intellectual Property and Disputes,” Innovator’s Edge Series, Aug 2021
- Speaker, “IP 101, The Basics for Biotech & Life Science Startups,” Tufts Launchpad | Biolabs, Oct 2018
Wilson Sonsini Goodrich & Rosati advised Prime Medicine on IP matters related to the offering. The Wilson Sonsini team included Lou Lieto, Clark Lin, Rachna Ujwal, and Esther Cynn.
- Privacy Policy
- Terms of Use
- Accessibility